| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |